NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma

April 13, 2021 | Comments Off on NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma

Cancers 2021 March 29 [Link] Haitang Yang, Sean R R Hall, Beibei Sun, Liang Zhao, Yanyun Gao, Ralph A Schmid, Swee T Tan, Ren-Wang Peng, Feng Yao Abstract (1) Inactivation…

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT

April 12, 2021 | Comments Off on Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT

Cancers 2021 March 4 [Link] Kazuhiro Kitajima, Mitsunari Maruyama, Hiroyuki Yokoyama, Toshiyuki Minami, Takashi Yokoi, Akifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa, Koichiro Yamakado Abstract…

Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression

April 7, 2021 | Comments Off on Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression

Scientific Reports 2021 April 1 [Link] Sara Busacca, Qi Zhang, Annabel Sharkey, Alan G Dawson, David A Moore, David A Waller, Apostolos Nakas, Carolyn Jones, Kelvin Cain, Jin-Li Luo, Adriana…

Bisecting-GlcNAc on Asn388 is characteristic to ERC/mesothelin expressed on epithelioid mesothelioma cells

April 6, 2021 | Comments Off on Bisecting-GlcNAc on Asn388 is characteristic to ERC/mesothelin expressed on epithelioid mesothelioma cells

Journal of Biochemistry 2021 April 1 [Link] Haruhiko Fujihira, Daisuke Takakura, Atsushi Matsuda, Masaaki Abe, Michiyo Miyazaki, Tomomi Nakagawa, Kazunori Kajino, Kaori Denda-Nagai, Miki Noji, Okio Hino, Tatsuro Irimura Abstract…

Utility of SOX6 and DAB2 for the Diagnosis of Malignant Mesothelioma

April 5, 2021 | Comments Off on Utility of SOX6 and DAB2 for the Diagnosis of Malignant Mesothelioma

The American Journal of Surgical Pathology 2021 March 29 [Link] Julia R Naso, Simon Cheung, Diana N Ionescu, Andrew Churg Abstract The separation of malignant mesothelioma from non-small cell lung…

High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer

April 1, 2021 | Comments Off on High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer

ERJ Open Research 2021 March 22 [Link] Lars Hagmeyer, Stephan Schäfer, Marianne Engels, Anja Pietzke-Calcagnile, Marcel Treml, Simon-Dominik Herkenrath, Matthias Heldwein, Khosro Hekmat, Sandhya Matthes, Andreas Scheel, Jürgen Wolf, Reinhard…

Interobserver Variability of Quantitative and Qualitative Assessment Using MRI in Malignant Pleural Mesothelioma

March 31, 2021 | Comments Off on Interobserver Variability of Quantitative and Qualitative Assessment Using MRI in Malignant Pleural Mesothelioma

Radiology Cardiothoracic Imaging 2020 April 30 [Link] Ritu R Gill, David J Murphy, Ravi T Seethamraju, Emanuele Mazzola, Raphael Bueno, William G Richards Abstract Purpose: To evaluate the interobserver variability…

The prognostic value of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography parameters in patients with malignant pleural mesothelioma

March 30, 2021 | Comments Off on The prognostic value of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography parameters in patients with malignant pleural mesothelioma

Turk Gogus Kalp Damar Cerrahisi Derg 2021 January 13 [Link] Bülent Mustafa Yenigün, Yusuf Kahya, Çiğdem Soydal, Nihal Ata Tutkun, Gökhan Kocaman, Emre Muhammed Koçak, Elgin Özkan, Serpil Dizbay Sak,…

Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting

March 29, 2021 | Comments Off on Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting

Future Oncology 2021 March 26 [Link] David M Waterhouse, Esmond D Nwokeji, Marley Boyd, John R Penrod, Janet L Espirito, Nicholas J Robert, Melinda J Daumont Abstract Aim: To assess…

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

March 26, 2021 | Comments Off on Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

BMC Cancer 2021 March 20 [Link] Rui Kitadai, Tatsunori Shimoi, Kazuki Sudo, Emi Noguchi, Yusuke Nagata, Ryoichi Sawada, Atsuo Takashima, Narikazu Boku, Kan Yonemori Abstract Background: Standard treatment for malignant…

Categories